A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease.

Journal:

Kidney International

Published:

2025-10-12

DOI:

10.1016/j.kint.2025.08.037

Affiliations:

5

Authors:

14

Go to article

Institutions	Authors	Share
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	11.500000 11.500000	0.82
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	1.000000	0.07
UNM Health Sciences Center (HSC), United States of America (USA)	1.000000	0.07
VA Eastern Colorado Health Care System, United States of America (USA)	0.500000	0.04

Interested in Clinical Sciences?